Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin

Drug Des Devel Ther. 2015 May 22;9:2705-19. doi: 10.2147/DDDT.S80948. eCollection 2015.

Abstract

To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethylene glycol (PEG) was synthesized and then loaded with DNR and Tet simultaneously to construct DNR/Tet-PLGA-PLL-PEG-NPs using a modified double-emulsion solvent evaporation/diffusion method. And to increase the targeted antitumor effect, DNR/Tet-PLGA-PLL-PEG-NPs were further modified with transferrin (Tf) due to its specific binding to Tf receptors (TfR), which is highly expressed on the surface of tumor cells. In this study, the influence of the diversity of formulation parameters was investigated systematically, such as drug loading, mean particle size, molecular weight, the concentration of PLGA-PLL-PEG-Tf, volume ratio of acetone to dichloromethane, the concentration of polyvinyl alcohol (PVA) in the external aqueous phase, the volume ratio of the internal aqueous phase to the external aqueous phase, and the type of surfactants in the internal aqueous phase. Meanwhile, its possible effect on cell viability was evaluated. Our results showed that the regular spherical DNR/Tet-PLGA-PLL-PEG-Tf-NPs with a smooth surface, a relatively low polydispersity index, and a diameter of 213.0±12.0 nm could be produced. The encapsulation efficiency was 70.23%±1.91% for DNR and 86.5%±0.70% for Tet, the moderate drug loading was 3.63%±0.15% for DNR and 4.27%±0.13% for Tet. Notably, the accumulated release of DNR and Tet could be sustained over 1 week, and the Tf content was 2.18%±0.04%. In cell viability tests, DNR/Tet-PLGA-PLL-PEG-Tf-NPs could inhibit the proliferation of K562/ADR cells in a dose-dependent manner, and the half maximal inhibitory concentration value (total drug) of DNR/Tet-PLGA-PLL-PEG-Tf-NPs was lower than that of DNR, a mixture of DNR and Tet, and DNR/Tet-PLGA-PLL-PEG-NPs. These results clearly indicate that the PLGA-PLL-PEG formulation is a potential drug delivery system for hydrophilic and hydrophobic drugs, and that Tf modification may increase its targeting properties.

Keywords: PEG; PLGA; PLL; daunorubicin; tetrandrine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Benzylisoquinolines / administration & dosage*
  • Benzylisoquinolines / chemistry
  • Benzylisoquinolines / pharmacology
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Daunorubicin / administration & dosage*
  • Daunorubicin / chemistry
  • Daunorubicin / pharmacology
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Drug Liberation
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • K562 Cells
  • Lactic Acid / chemistry
  • Nanoparticles
  • Particle Size
  • Polyethylene Glycols / chemistry
  • Polyglycolic Acid / chemistry
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polylysine / chemistry
  • Transferrin / chemistry*

Substances

  • Antineoplastic Agents
  • Benzylisoquinolines
  • Delayed-Action Preparations
  • Drug Carriers
  • Transferrin
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polylysine
  • Polyglycolic Acid
  • tetrandrine
  • Lactic Acid
  • Polyethylene Glycols
  • Daunorubicin